Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

A Single Patient Compassionate Use of MBM-02 (Tempol) for the Treatment of Prostate Cancer

  • Read more about A Single Patient Compassionate Use of MBM-02 (Tempol) for the Treatment of Prostate Cancer

Moxibustion Plus Cupping in Convalescent Patients With COVID-19

  • Read more about Moxibustion Plus Cupping in Convalescent Patients With COVID-19

A Study of N-acetylcysteine in Patients With COVID-19 Infection

  • Read more about A Study of N-acetylcysteine in Patients With COVID-19 Infection

PET/CT Imaging in COVID-19 Patients

  • Read more about PET/CT Imaging in COVID-19 Patients

Harnessing Online Peer Education Online Support Intervention for COVID-19 (HOPE COVID-19)

  • Read more about Harnessing Online Peer Education Online Support Intervention for COVID-19 (HOPE COVID-19)

Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy

  • Read more about Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy

Convalescent Plasma Collection and Treatment in Pediatrics and Adults

  • Read more about Convalescent Plasma Collection and Treatment in Pediatrics and Adults

Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS)

  • Read more about Mesenchymal Stem Cells (MSCs) in Inflammation-Resolution Programs of Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS)

Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations

  • Read more about Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Adults With Polypharmacy Using Data From Large Medicare and Commercially Insured Populations

Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19

  • Read more about Safety and Efficacy of Therapeutic Anticoagulation on Clinical Outcomes in Hospitalized Patients With COVID-19

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 225
  • Page 226
  • Page 227
  • Page 228
  • Current page 229
  • Page 230
  • Page 231
  • Page 232
  • Page 233
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA